Sort   by:  
 Page size 
UnknownRecurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7.
Not available
S-EPMC8185188 | biostudies-literature
UnknownCommon variation at PPARGC1A/B and change in body composition and metabolic traits following preventive interventions: the Diabetes Prevention Program.
Not available
S-EPMC4154629 | biostudies-literature
UnknownExtension of type 2 diabetes genome-wide association scan results in the diabetes prevention program.
Not available
S-EPMC2518503 | biostudies-literature
UnknownComparison of echocardiographic and cardiac magnetic resonance imaging measurements of functional single ventricular volumes, mass, and ejection fraction (from the Pediatric Heart Network Fontan Cross-Sectional Study).
Not available
S-EPMC2741330 | biostudies-literature
UnknownAssociation of BMI and Cognitive Performance in the Diabetes Prevention Program Outcomes Study.
Not available
S-EPMC12636062 | biostudies-literature
UnknownEvaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance.
Not available
S-EPMC3075321 | biostudies-literature
UnknownGenomic reconstruction of the SARS-CoV-2 epidemic in England.
Not available
S-EPMC8674138 | biostudies-literature
UnknownFunctional health status in children and adolescents after Fontan: comparison of generic and disease-specific assessments.
Not available
S-EPMC4068336 | biostudies-literature
UnknownCirculating natriuretic peptide concentrations reflect changes in insulin sensitivity over time in the Diabetes Prevention Program.
Not available
S-EPMC4158711 | biostudies-literature
UnknownTwo phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Not available
S-EPMC4159618 | biostudies-literature
Sort   by:  
 Page size